HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David J Pinsky Selected Research

Methotrexate (Mexate)

5/2014Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David J Pinsky Research Topics

Disease

16Inflammation (Inflammations)
03/2024 - 11/2002
14Thrombosis (Thrombus)
03/2024 - 04/2003
13Stroke (Strokes)
01/2016 - 04/2002
10Ischemia
05/2009 - 06/2002
9Myocardial Infarction
08/2011 - 05/2006
8Atherosclerosis
12/2022 - 04/2007
7Infarction (Infarctions)
05/2014 - 04/2002
7Coronary Artery Disease (Coronary Atherosclerosis)
07/2009 - 05/2006
6Reperfusion Injury
01/2016 - 07/2006
6Hypoxia (Hypoxemia)
01/2016 - 06/2002
6Acute Coronary Syndrome
08/2011 - 05/2006
3Atherosclerotic Plaque (Atheroma)
12/2022 - 05/2006
3Venous Thrombosis (Deep-Vein Thrombosis)
01/2019 - 01/2017
3Lung Injury
04/2014 - 12/2002
3Cerebral Infarction
05/2009 - 04/2002
3Bronchitis
07/2007 - 11/2002
3Chest Pain (Chest Pains)
05/2007 - 05/2006
2Fibrosis (Cirrhosis)
01/2023 - 07/2006
2Bronchiolitis Obliterans
01/2023 - 07/2006
2Kidney Diseases (Kidney Disease)
12/2022 - 01/2018
2Rupture
12/2017 - 05/2006
2Ischemic Stroke
01/2016 - 10/2012
2Hypertrophy
01/2016 - 06/2010
2Hyperoxia
04/2014 - 07/2012
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2012 - 04/2002
2Vascular Diseases (Vascular Disease)
10/2007 - 04/2003
2Brain Injuries (Brain Injury)
07/2007 - 10/2005
2Bronchiolitis
07/2007 - 11/2002
2Leukostasis
03/2006 - 12/2002
1COVID-19
03/2024
1Paralysis (Palsy)
03/2024
1Thromboinflammation
01/2023
1Aortic Dissection
01/2020
1Infections
01/2020
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019

Drug/Important Bio-Agent (IBA)

8Adenosine Diphosphate (ADP)IBA
06/2017 - 04/2002
7Adenosine Triphosphate (ATP)IBA
06/2017 - 04/2003
6NucleotidesIBA
01/2023 - 04/2003
5Oxygen (Dioxygen)IBA
01/2016 - 06/2002
5Adenosine Monophosphate (AMP)IBA
01/2016 - 01/2005
5Proteins (Proteins, Gene)FDA Link
04/2014 - 04/2006
5Biomarkers (Surrogate Marker)IBA
08/2011 - 07/2007
5Complement System Proteins (Complement)IBA
12/2007 - 10/2005
4LigandsIBA
05/2024 - 11/2002
4EnzymesIBA
01/2019 - 07/2005
4FibrinIBA
12/2017 - 04/2002
4Messenger RNA (mRNA)IBA
04/2014 - 03/2006
3ChemokinesIBA
05/2024 - 04/2007
3Adenosine (Adenocard)FDA LinkGeneric
01/2023 - 01/2012
3P-SelectinIBA
01/2023 - 11/2002
3CytokinesIBA
04/2014 - 07/2006
3C-Reactive ProteinIBA
08/2011 - 12/2007
3Transcription Factors (Transcription Factor)IBA
03/2007 - 07/2002
2Carbon MonoxideIBA
01/2023 - 04/2014
2Plasminogen Activators (Plasminogen Activator)IBA
12/2022 - 05/2009
2Apolipoproteins E (ApoE)IBA
01/2020 - 08/2015
2ApolipoproteinsIBA
01/2020 - 08/2015
2Antiphospholipid AntibodiesIBA
01/2019 - 01/2017
2triphosphoric acid (triphosphate)IBA
12/2017 - 04/2003
2Diphosphates (Pyrophosphates)IBA
01/2016 - 05/2009
2Immunologic Factors (Immunomodulators)IBA
01/2016 - 10/2011
2Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
04/2014 - 07/2005
2AntioxidantsIBA
07/2012 - 08/2006
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
09/2011 - 08/2006
2Dehydroascorbic AcidIBA
09/2011 - 08/2006
2Plasminogen Activator Inhibitor 1IBA
05/2009 - 03/2007
2NucleosidesIBA
05/2009 - 04/2003
2Apyrase (ATP Diphosphatase)IBA
05/2009 - 04/2003
2Fibrinogen (Factor I)FDA Link
03/2009 - 12/2007
2AdiponectinIBA
04/2008 - 10/2006
2adhesion receptorIBA
03/2008 - 11/2002
2AnticoagulantsIBA
03/2007 - 06/2002
2DNA (Deoxyribonucleic Acid)IBA
02/2007 - 03/2006
2Neuroprotective AgentsIBA
10/2006 - 08/2006
2Phenobarbital (Luminal)FDA Link
07/2005 - 11/2002
2Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2005 - 04/2003
1Complement C5a (Complement 5a)IBA
05/2024
1aconitate decarboxylaseIBA
05/2024
1Thromboplastin (Tissue Factor)IBA
03/2024
1NexusIBA
03/2024
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2024
1Angiotensin-Converting Enzyme 2IBA
03/2024
1Interleukin-6 (Interleukin 6)IBA
03/2024
1ProteomeIBA
03/2024
1LipopolysaccharidesIBA
01/2023
1Drug CarriersIBA
01/2023
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2022
1CholesterolIBA
12/2022
1SubtilisinIBA
12/2022
1Urokinase Plasminogen Activator ReceptorsIBA
12/2022
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
12/2022
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2020
1von Willebrand FactorIBA
01/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2019
1InterleukinsIBA
01/2019

Therapy/Procedure

5Lung Transplantation
01/2023 - 07/2006
3Therapeutics
01/2023 - 08/2006
2Transplantation
01/2023 - 07/2005
2Ligation
01/2019 - 12/2017